Distinguished Investigator Grant for Anders H. Lund
Professor and group leader Anders H. Lund from Biotech Research & Innovation Centre, BRIC has received a Distinguished Investigator grant of DKK 10 million over five years from the Novo Nordisk Foundation for the research project ”In vivo investigations of the ribosome code.”
About the project
The ribosome is the key interpreter of genetic information in all living organisms. However, despite its pivotal role, very little is known about how the ribosome is regulated. The project explores the hypothesis that modifications of the ribosomal RNA are regulatory for ribosome function and impacts on protein translation. Understanding how the ribosome is regulated to tune translation will provide a better understanding of how gene expression programmes are faithfully executed and may provide insight into diseases in which translational control is pathologically hijacked.
Anders Lund says: "I am honoured to receive the Distinguished Investigator grant from the Novo Nordisk Foundation. With this very significant grant I can truly devote time and ressources into pushing our research further. The project explores how the production of cells is regulated within our cells. It is a very essential biological process that affects our everyday lives and development, but also plays a main role in many diseases. It is my hope that the results of this project will benefit both basic and application-oriented research."
Distinguished Investigator Grants
The Distinguished Investigator grants are a part of the Novo nordisk Foundations new ’Research Leader Programme’, which was established in 2017. The programme focusses on supporting basic research within biomedicine and bioscience and consists of three different types of grants: Distinguished Investigator, Hallas-Møller Ascending Investigator and Hallas-Møller Emerging Investigator. The Distinguished Investigator grants are targeted at professors at the highest international level.
Communications Officer Anne Rahbek-Damm